About
Dan Crowley is co-founder and CEO of RemedyBio, and is focused on strategic leadership of the company, supporting our great team, and building transformational partnerships with industry leaders. Prior to RemedyBio, Dan co-founded and led Genomics Medicine Ireland (acquired in 2018) and was a Venture Partner with ARCH Venture Partners. He serves on the board of the AMBER Centre for Advanced Materials and Bioengineering Research headquartered at Trinity College Dublin. Dan holds a BA and MSc from Trinity College Dublin, a PDip from Oxford University, received his MBA from Cornell where he was an Angear Merit Scholar, and is a Kauffman Fellow.
Position in the VCSift Database
- • 616 investors hold the CEO & Co-Founder role in VCSift. Daniel Crowley is one of them.
- • 416 investors are based in Dublin, Dublin, Ireland.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Dublin, Ireland
Contact Information
linkedin.com/in/••••••••
Find more investors like Daniel
Search Investors